144 related articles for article (PubMed ID: 2496130)
21. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426
[TBL] [Abstract][Full Text] [Related]
22. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis.
Al-Ssum RM; Harris DM
J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099
[No Abstract] [Full Text] [Related]
23. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa.
Galloway DR; Hedstrom RC; Pavlovskis OR
Infect Immun; 1984 May; 44(2):262-7. PubMed ID: 6425217
[TBL] [Abstract][Full Text] [Related]
24. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia.
al-Ssum RM
Microbiologica; 1992 Oct; 15(4):355-9. PubMed ID: 1435349
[TBL] [Abstract][Full Text] [Related]
25. Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.
Holt PS; Misfeldt ML
Infect Immun; 1984 Jul; 45(1):227-33. PubMed ID: 6429047
[TBL] [Abstract][Full Text] [Related]
26. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
[TBL] [Abstract][Full Text] [Related]
27. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
[No Abstract] [Full Text] [Related]
28. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
29. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease.
Woods DE; Sokol PA
Clin Invest Med; 1986; 9(2):108-12. PubMed ID: 3089661
[TBL] [Abstract][Full Text] [Related]
30. Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
Ogaard AR; Cryz SJ; Berdal BP
Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):217-23. PubMed ID: 3929560
[TBL] [Abstract][Full Text] [Related]
31. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
[TBL] [Abstract][Full Text] [Related]
32. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1983 Mar; 39(3):1072-9. PubMed ID: 6404817
[TBL] [Abstract][Full Text] [Related]
33. Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.
Snell K; Holder IA; Leppla SA; Saelinger CB
Infect Immun; 1978 Mar; 19(3):839-45. PubMed ID: 417031
[TBL] [Abstract][Full Text] [Related]
34. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15(1):47-50. PubMed ID: 3106228
[TBL] [Abstract][Full Text] [Related]
35. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
[TBL] [Abstract][Full Text] [Related]
36. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice.
Miyazaki S; Matsumoto T; Tateda K; Ohno A; Yamaguchi K
J Med Microbiol; 1995 Sep; 43(3):169-75. PubMed ID: 7650723
[TBL] [Abstract][Full Text] [Related]
37. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
[TBL] [Abstract][Full Text] [Related]
38. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa.
Vasil ML; Ogle JW; Grant CC; Vasil AI
Antibiot Chemother (1971); 1987; 39():264-78. PubMed ID: 3118789
[No Abstract] [Full Text] [Related]
39. Detection of exotoxin A produced by Pseudomonas aeruginosa.
Chen CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Apr; 3(4):306-8. PubMed ID: 3132561
[No Abstract] [Full Text] [Related]
40. Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by
Zhang J; Wan C; Yu B; Gao C; Zhao L; Cheng X; Yang F; Gu H; Zou Q; Gu J; Wang X
Hum Vaccin Immunother; 2019; 15(12):2993-3002. PubMed ID: 31116632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
